| Financial Year |
March 31 2023 |
| Monetary Funds |
350,916,493.66 |
| Held-for-trading Financial Assets |
155,469,178.08 |
| Notes Receivable |
1,818,486.58 |
| Accounts Receivable |
536,268,710.20 |
| Advances to Suppliers |
48,798,618.61 |
| Other Receivables |
36,250,391.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
776,620,753.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,123,903.94 |
| Total Current Assets |
2,149,490,461.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,977,813.31 |
| Investment Properties |
5,005,670.74 |
| Fixed Assetes |
377,142,653.67 |
| Under-construction Projects |
84,818,004.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
135,512,811.47 |
| R&D expenses |
-- |
| Goodwill |
438,928,614.31 |
| Long-Term Deferred and Prepaid Expenses |
3,638,206.77 |
| Deferred Income Tax Assets |
14,480,935.59 |
| Other Non-Current Assets |
907,996.99 |
| Sub-Total of Non-Current Assets |
1,202,808,744.57 |
| Total Assets |
3,352,299,206.35 |
| Short-Term Loans |
155,040,632.26 |
| Trading Financial liabilities |
-- |
| Notes Payable |
167,838,291.10 |
| Accounts Payable |
330,770,712.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
33,156,637.96 |
| Taxes Payable |
38,359,481.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,475,858.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
45,679,114.37 |
| Other Current Liabilities |
17,418,195.16 |
| Sub-Total of Current Liabilities |
1,346,296,712.55 |
| Long-term Loans |
182,351,490.00 |
| Bonds Payable |
253,063,287.13 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,832,222.29 |
| Deferred Income Tax Liabilities |
5,315,428.77 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
532,754,974.82 |
| Total Liabilities |
1,879,051,687.37 |
| Paid-In Capital(Or Share Stock) |
300,328,145.00 |
| Capital Surplus |
280,019,865.08 |
| Surplus Reserve |
82,631,832.77 |
| LESS:Treasury Stock |
19,995,920.80 |
| Undistributed Profits |
761,905,902.83 |
| Minority Stockholder's Interest |
5,525,368.87 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,467,722,150.10 |
| Owner's Equity（Stockholder's Equity） |
1,473,247,518.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,352,299,206.34 |
